K2M Group Holdings Inc (NASDAQ:KTWO) CFO Gregory S. Cole sold 2,350 shares of the company’s stock in a transaction on Tuesday, August 15th. The stock was sold at an average price of $24.08, for a total transaction of $56,588.00. Following the completion of the transaction, the chief financial officer now directly owns 55,158 shares of the company’s stock, valued at $1,328,204.64. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Gregory S. Cole also recently made the following trade(s):

  • On Friday, August 11th, Gregory S. Cole sold 39,357 shares of K2M Group Holdings stock. The stock was sold at an average price of $23.37, for a total transaction of $919,773.09.
  • On Saturday, July 1st, Gregory S. Cole sold 956 shares of K2M Group Holdings stock. The stock was sold at an average price of $24.33, for a total transaction of $23,259.48.

Shares of K2M Group Holdings Inc (NASDAQ KTWO) traded down 0.021% during midday trading on Wednesday, reaching $24.045. 377,686 shares of the company’s stock traded hands. The stock has a 50 day moving average of $24.04 and a 200-day moving average of $21.99. The stock’s market cap is $1.04 billion. K2M Group Holdings Inc has a 12 month low of $15.45 and a 12 month high of $25.99.

K2M Group Holdings (NASDAQ:KTWO) last released its quarterly earnings results on Tuesday, August 1st. The medical device company reported ($0.21) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.01. K2M Group Holdings had a negative net margin of 13.79% and a negative return on equity of 14.26%. The company had revenue of $65.70 million for the quarter, compared to analyst estimates of $66.26 million. During the same period last year, the firm earned ($0.27) earnings per share. The firm’s revenue was up 11.0% on a year-over-year basis. On average, equities research analysts forecast that K2M Group Holdings Inc will post ($0.78) EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This report was published by American Banking News and is owned by of American Banking News. If you are reading this report on another site, it was illegally stolen and republished in violation of US & international copyright & trademark law. The correct version of this report can be viewed at https://www.americanbankingnews.com/2017/08/16/gregory-s-cole-sells-2350-shares-of-k2m-group-holdings-inc-ktwo-stock.html.

KTWO has been the subject of a number of research analyst reports. Oppenheimer Holdings, Inc. set a $29.00 target price on shares of K2M Group Holdings and gave the stock a “buy” rating in a research note on Wednesday, August 2nd. JMP Securities reissued an “outperform” rating and set a $30.00 price target (up from $27.00) on shares of K2M Group Holdings in a research report on Wednesday, June 28th. Royal Bank Of Canada reissued a “buy” rating and set a $26.00 price target on shares of K2M Group Holdings in a research report on Thursday, July 20th. Needham & Company LLC reissued a “buy” rating on shares of K2M Group Holdings in a research report on Wednesday, August 2nd. Finally, BidaskClub raised shares of K2M Group Holdings from a “hold” rating to a “buy” rating in a research report on Wednesday, July 19th. Two equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $26.25.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. 1st Global Advisors Inc. raised its position in K2M Group Holdings by 2.9% in the first quarter. 1st Global Advisors Inc. now owns 13,101 shares of the medical device company’s stock worth $269,000 after buying an additional 369 shares during the last quarter. Legal & General Group Plc raised its stake in shares of K2M Group Holdings by 9.1% in the first quarter. Legal & General Group Plc now owns 6,763 shares of the medical device company’s stock valued at $138,000 after buying an additional 564 shares in the last quarter. Macquarie Group Ltd. raised its stake in shares of K2M Group Holdings by 0.3% in the second quarter. Macquarie Group Ltd. now owns 200,656 shares of the medical device company’s stock valued at $4,888,000 after buying an additional 581 shares in the last quarter. Wells Fargo & Company MN raised its stake in shares of K2M Group Holdings by 0.9% in the second quarter. Wells Fargo & Company MN now owns 63,322 shares of the medical device company’s stock valued at $1,542,000 after buying an additional 590 shares in the last quarter. Finally, American International Group Inc. raised its stake in shares of K2M Group Holdings by 7.1% in the first quarter. American International Group Inc. now owns 15,847 shares of the medical device company’s stock valued at $325,000 after buying an additional 1,047 shares in the last quarter. 98.55% of the stock is currently owned by institutional investors.

K2M Group Holdings Company Profile

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Insider Buying and Selling by Quarter for K2M Group Holdings (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.